respiratory disorderとは 意味・読み方・使い方

The use of EP_4 agonist improves various symptoms accompanying to neurodegenerative diseases (for example, tremor, rigidity, akinesia, oligokinesia, bradykinesia, postural reflex disorder, autonomic disturbance, pulsion, gait disorder, depression, dysmnesia, muscular atrophy, muscular depression, upper limb dysfunction, articulatory disorder, dysphagia, respiratory obstruction, palsy and paralysis).例文帳に追加

また、ＥＰ_４アゴニストを用いれば、神経変性疾患に伴う種々の症状（例えば、振戦、固縮、無動、寡動、動作緩慢、姿勢反射障害、自律神経障害、突進現象、歩行障害、うつ、記憶障害、筋萎縮、筋力低下、上肢機能障害、構音障害、嚥下障害、呼吸障害、しびれおよび麻痺等）の改善にも有用である。 - 特許庁

Thereby, actin-related impairments, such as ARDS (adult respiratory disease syndrome), fulgurant lever necrosis, acute hepatic insufficiency, and muscular injury and disorder, and other impairments characterized by temporary rise of BUN (blood urine nitrogen) and a creatinine level can be treated.例文帳に追加

ＡＲＤＳ、閃光性肝臓壊死、急性肝不全、筋肉損傷及び障害等のアクチン関連障害、並びにＢＵＮ及びクレアチニン・レベルの一時的な上昇を特徴とするその他の障害を処置する方法を提供する。 - 特許庁

To provide a wheelchair allowing persons having severe physical disorder such as dysphagia and respiratory disturbance to easily take an optimal posture by inclining the whole seat body into the front/rear and the left/right or rotationally tuning it around a vertical axis.例文帳に追加

シート全体を前後左右に傾け、或いは垂直軸回りに回動させることができ、嚥下障害や呼吸障害等の重度の身体障害を有する者等にとって好適な姿勢を容易に取らせることができる車椅子の提供を目的とする。 - 特許庁

This invention further relates to uses of the lipid or phospholipid conjugates for the preparation of medicaments for treating a subject suffering from sepsis, a dermatologic condition, an intestinal disease, a disease or disorder of the central nervous system associated with an inflammatory response and/or an obstructive respiratory disease.例文帳に追加

本発明は、さらに敗血症、皮膚科学的症状、腸疾病、炎症性反応に伴う中枢神経系の疾病又は疾患及び／又は閉塞性呼吸器疾病に罹患した患者を治療するための医薬の調製のための、脂質又はリン脂質複合体の使用を提供する。 - 特許庁

The compound of the present invention and its pharmaceutically acceptable compositions are useful for treating or preventing various diseases, disorders or symptoms including an immune disorder trouble, an inflammatory disease, an allergic disease, an autoimmune disease, a proliferative trouble, an immunity-mediated disease and a respiratory organ trouble.例文帳に追加

本発明の化合物およびその薬学的に受容可能な組成物は、免疫不全障害、炎症性疾患、アレルギー性疾患、自己免疫疾患、増殖性障害、免疫媒介性疾患、または呼吸器障害を含む、各種の疾患、障害または症状を処置または防止するのに有用である。 - 特許庁

To provide compounds useful for prevention and/or treatment of diseases such as allergic diseases (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mast cell disease, systemic mast cell activation failure, anaphylactic shock, respiratory tract contraction, urticaria, eczema, diseases associated with itch, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion injury, cerebrovascular disorder, rheumatoid arthritis, pleuritis, ulcerative colitis.例文帳に追加

アレルギー性疾患（アレルギー性鼻炎、アレルギー性結膜炎、アトピー性皮膚炎、気管支喘息、食物アレルギー等）、全身性肥満細胞症、全身性肥満細胞活性化障害、アナフィラキシーショック、気道収縮、蕁麻疹、湿疹、痒みを伴う疾患、炎症、慢性閉塞性肺疾患、虚血再灌流障害、脳血管障害、慢性関節リウマチ、胸膜炎、潰瘍性大腸炎等の疾患の予防および／または治療に有用な化合物の提供。 - 特許庁